MedTrace Logo

A Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency

NCT02422901 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2022-04-26

No results posted yet for this study

Summary

The aim of this long-term observational study is the documentation of the use of PASCORBIN® 7.5 g in patients with vitamin C deficiency. Regarding the vitamin C deficiency, the investigators focus on the acquisition of data of the underlying diseases and the reduction of symptoms, that are related to oxidative stress and vitamin-C-deficiency. Next to this, exact assessment of medical tolerance and details of treatment requirements are further aims. Here the investigators take into account acute and chronic underlying medical conditions. Further health economic data are collected.

Conditions

Interventions

DRUG

vitamin C

According to the character of an observational study no intervention other than the administration of Pascorbin® 7.5g (which is administered routinely in these cases) is provided.

Sponsors & Collaborators

  • Pascoe Pharmazeutische Praeparate GmbH

    lead INDUSTRY

Principal Investigators

  • Holger Michels, MD & M. Sci. · Pascoe Pharmazeutische Praeparate GmbH

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2022-11-30
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02422901 on ClinicalTrials.gov